Endo International plc, et al.
Case Number:
7:22-bk-22549
Court:
Nature of Suit:
Firms
- Akin Gump
- Alston & Bird
- ArentFox Schiff
- ASK LLP
- Barton LLP
- Beck Chaet
- Bielli & Klauder
- Binder & Schwartz
- Blank Rome
- Bond Schoeneck
- Brown & Connery
- Brown Rudnick
- Carter Ledyard
- Chiesa Shahinian
- Chipman Brown
- Cohen Weiss
- Connell Foley
- Cooley LLP
- Covington & Burling
- Cullen & Dykman
- Davidson Bowie
- Davidson Fink
- Davis Polk
- Dickie McCamey
- Duane Morris
- Fishman Haygood
- Fleischer Fleischer
- Foley & Lardner
- Foran Glennon
- Fox Rothschild
- FrankGecker
- Frejka PLLC
- Freshfields
- Gibson Dunn
- Glenn Agre
- Godfrey & Kahn
- Goldman Ismail
- Haynes & Boone
- Herzfeld Suetholz
- Hodgson Russ
- Hunton Andrews
- Husch Blackwell
- Jenner & Block
- Jones Day
- Katten Muchin
- Kelley Drye
- Kelly & Brennan
- Kirkland & Ellis
- Klehr Harrison
- Klestadt Winters
- K&L Gates
- Kline & Specter
- Kohner Mann
- Kramer Levin
- Kurzman Eisenberg
- Latham & Watkins
- Lemery Greisler
- Levenfeld Pearlstein
- Linebarger Goggan
- Locke Lord
- Masuda Funai
- Mayer Brown
- McCarter & English
- McElroy Deutsch
- McGrail & Bensinger
- Miller Nash LLP
- Nelson Mullins
- Nixon Peabody
- Norton Rose
- Obermayer Rebmann
- O'Melveny & Myers
- Orrick Herrington
- Paul Weiss
- Perkins Coie
- Phillips Lytle
- Pillsbury Winthrop
- Porzio Bromberg
- Potter Anderson
- Pullman & Comley
- Robinson & Cole
- Ross Smith & Binford
- Rubin LLC
- Saul Ewing
- Schiller Knapp
- Seward & Kissel
- Shafferman & Feldman
- Shipman & Goodwin
- Sills Cummis
- Simpson Thacher & Bartlett LLP
- Skadden Arps
- Squire Patton
- Stark & Stark
- Stevens & Lee
- Stranch Jennings
- Stutzman Bromberg
- Taft Stettinius
- Tarter Krinsky
- Togut Segal
- Troutman Pepper
- Tucker Arensberg
- Wachtell Lipton
- Warner Norcross
- Weltman Weinberg
- White and Williams
- White & Case
- Willkie Farr
- WilmerHale
- Young Conaway
Companies
- AbbVie Inc.
- Ahold Delhaize
- AIS Portfolio Services LLC
- Altaris Capital Partners LLC
- Alvarez & Marsal Holdings LLC
- American Federation of State County & Municipal Employees
- Amneal Pharmaceuticals Inc.
- Anchen Pharmaceuticals Inc.
- Aspen Insurance Holdings Ltd.
- AstraZeneca PLC
- Auxilium Pharmaceuticals, Inc.
- Berkeley Research Group LLC
- Cardinal Health Inc.
- Cencora Inc.
- Collegium Pharmaceutical Inc.
- Computershare Ltd.
- Consolidated Edison Inc.
- Constellation Energy Corp.
- Cornerstone Research Inc.
- CVS Health Corp.
- Dayforce Inc.
- DTE Energy Co.
- Ducera Partners LLC
- Dundon Advisers LLC
- Endo International PLC
- Ernst & Young LLP
- Evidera
- Evoqua Water Technologies LLC
- Express Scripts Holding Co.
- Ford Motor Co.
- Glenmark Pharmaceuticals Ltd.
- Grant Thornton LLP
- Grunenthal Group
- Henry Schein Inc.
- Jefferies Financial Group Inc.
- Johnson Controls International PLC
- Johnson & Johnson
- KPMG International
- Lazard Ltd.
- Lexington Insurance Co.
- Liberty Mutual Insurance Group
- Life Technologies Corporation
- McKesson Corp.
- Medco Health Solutions Inc.
- Merck & Co. Inc.
- Novitium Pharma LLC
- Optum Inc.
- OptumRx Inc.
- Oracle Corp.
- Par Pharmaceutical Cos. Inc.
- Patheon Inc.
- PCI Pharma Services
- PECO Energy Co.
- Pfizer Inc.
- PricewaterhouseCoopers LLP
- Province LLC
- SAP AG
- SAS Institute Inc.
- Teikoku Pharma USA Inc.
- Teva Pharmaceutical Industries Ltd.
- The Cigna Group
- The Hartford Financial Services Group Inc.
- Thermo Fisher Scientific Inc.
- Toyota Industries Commercial Finance Inc.
- UMB Financial Corp.
- United BioSource Corp.
- United Steelworkers
- U.S. Bancorp
- Walmart Inc.
- Wilmington Trust Corp.
Government Agencies
- Missouri Department of Revenue
- National Labor Relations Board
- Rochester City School District
- State of Indiana
Sectors & Industries:
-
April 22, 2024
Endo Creditor Trust Asks For $50M In Litigation Financing
The committee of unsecured creditors in the Chapter 11 case of pharmaceutical company Endo International asked a New York bankruptcy judge Monday for permission to enter into a $50 million secondary financing facility to help the creditor trust created under the company's bankruptcy plan pursue litigation and settlements of potential claims.
-
March 20, 2024
Endo Plan To Trim $5B In Debt Confirmed By NY Judge
Drugmaker Endo International got a New York bankruptcy judge's approval for its Chapter 11 plan that aims to cut more than $5 billion in debt and hand over ownership to its lenders, roughly a month after it finalized a $465 million deal to resolve criminal and civil opioid claims.
-
February 29, 2024
Bankrupt Endo To Pay $465M To Resolve Opioid Claims
Drugmaker Endo International has agreed to pay as much as $465 million to resolve criminal and civil claims stemming from its sale and marketing of a powerful opioid, and will turn over its assets to a group of secured lenders who will operate the company under a new corporate structure.
-
February 02, 2024
Drugmaker Endo Wants To Extend Opioid Suit Pause
Endo has asked a New York bankruptcy judge to pause the opioid litigation leveled against it for five more months, asserting that the pharmaceutical company made "wide-ranging progress" in its Chapter 11 case and expects to have a reorganization plan confirmed by March.
-
September 21, 2023
Skadden Nabs $19M Fee For 4 Months' Work On Endo Ch. 11
Skadden Arps Slate Meagher & Flom LLP was cleared Thursday by a New York judge to be paid over $19 million for its work from January to April 2023 on the Chapter 11 bankruptcy of pharmaceutical company Endo International PLC.
-
July 20, 2023
Endo International Wins More Support For $6B Ch. 11 Sale
Bankrupt pharmaceutical company Endo International PLC told a New York judge Thursday that it has resolved objections from key stakeholders in its Chapter 11 case and garnered increased support for a $6 billion sale of its assets to a group of debtholders.
-
July 19, 2023
Endo Pitches Deal With Distributors Over Ch. 11 Sale Plan
Bankrupt pharmaceutical company Endo International asked a New York bankruptcy court Tuesday to approve a settlement with distributors, manufacturers and pharmacies over indemnification of claims in opioid litigation that should remove an obstacle blocking the sale of Endo's assets.
-
April 12, 2023
Endo Gets OK For $27M Deal With Novavax In Contract Fight
A New York bankruptcy judge on Wednesday gave Endo International permission to settle a contract dispute with COVID-19 vaccine maker Novavax for $27 million after the pharmaceutical company said Novavax may be heading for bankruptcy itself.
-
January 19, 2023
Endo Gets Approval For Fee Deal With State Governments
A New York bankruptcy judge Thursday gave Endo International permission to pick up the professional fees for a group of states with claims against the pharmaceutical maker for its opioid sales, saying it's in the company's interest to make the payments.
-
January 09, 2023
Endo Ch. 11 Could Stiff Future Opioid Claimants, Judge Told
Despite previous statements to the contrary, a proposed bankruptcy reorganization plan does not require embattled pharmaceutical company Endo International or any purchaser of its assets to establish a trust fund for future opioid victims, a future claims representative has argued.